Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network (SPSN) assessed interim 2016/17 influenza vaccine effectiveness (VE) against dominant influenza A(H3N2) viruses considered antigenically matched to the clade 3C.2a vaccine strain. Sequence analysis revealed substantial heterogeneity in emerging 3C.2a1 variants by province and over time. Adjusted VE was 42% (95% confidence interval: 18-59%) overall, with variation by province. Interim virological and VE findings reported here warrant further investigation to inform potential vaccine reformulation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316907 | PMC |
| http://dx.doi.org/10.2807/1560-7917.ES.2017.22.6.30460 | DOI Listing |
Publication Analysis
Top Keywords
vaccine effectiveness
8
influenza ah3n2
8
interim estimates
4
estimates 2016/17
4
vaccine
4
2016/17 vaccine
4
effectiveness influenza
4
ah3n2 canada
4
canada january
4
january 2017
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!